Janus Henderson Group
MXCT icon

Janus Henderson Group’s MaxCyte MXCT Stock Holding History

Janus Henderson Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,087
Closed -$117K – 2562
2024
Q3 		$117K Hold
30,087
– – ﹤0.01% 2502
2024
Q2 		$118K Sell
30,087
-472
-2% -$2.03K ﹤0.01% 2485
2024
Q1 		$128K Buy
30,559
+5
+0% +$23 ﹤0.01% 2492
2023
Q4 		$143K Sell
30,554
-74
-0.2% -$288 ﹤0.01% 2492
2023
Q3 		$95.4K Buy
30,628
+4
+0% +$16 ﹤0.01% 2522
2023
Q2 		$140K Sell
30,624
-83
-0.3% -$381 ﹤0.01% 2529
2023
Q1 		$152K Buy
30,707
+17,096
+126% +$84.2K ﹤0.01% 2552
2022
Q4 		$74.2K Sell
13,611
-12,389
-48% -$76K ﹤0.01% 2382
2022
Q3 		$168K Buy
26,000
+13,000
+100% +$72.5K ﹤0.01% 2438
2022
Q2 		$61K Hold
13,000
– – ﹤0.01% 2538
2022
Q1 		$91K Hold
13,000
– – ﹤0.01% 2575
2021
Q4 		$132K Buy
+13,000
New +$140K ﹤0.01% 2473

Other funds holding MXCT

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
RGI
River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Janus Henderson Group's MXCT Position: Q4 2024 in Review

Janus Henderson Group sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 30,087 shares — an estimated $117K sold.

Janus Henderson Group first reported a position in MXCT in Q4 2021 and held it in 12 quarters. The position peaked at $168K in Q3 2022. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • Janus Henderson Group reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
  • Janus Henderson Group sold 30,087 MaxCyte shares in Q4 2024, an estimated $117K.
  • Janus Henderson Group first reported a position in MaxCyte in Q4 2021 and held it in 12 quarters.
  • Janus Henderson Group's MaxCyte position peaked at $168K in Q3 2022.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.